Nanoparticle-based systems, such as recombinant human ferritin (rHF), represent a significant advance by functioning as scavengers for multiple types of ROS and inhibiting parallel cell death pathways (Qi, 2024)

The CVS Caremark standard step therapy protocol for obesity medications follows this sequence: Step 1: Generic oral weight-loss medications (must try for 90 days minimum) Phentermine 37.5 mg daily, OR Orlistat 120 mg three times daily, OR Naltrexone/bupropion ER (Contrave) Step 2: Preferred GLP-1 agonist (if Step 1 fails or contraindicated) Depends on plan formulary Some plans require trying Ozempic off-label before Wegovy Others require trying liraglutide (Saxenda) first Step 3: Wegovy (if Steps 1 and 2 fail) Requires documentation of inadequate response (less than 5% body weight loss after 90 days) OR intolerable side effects OR documented contraindication "Failure" is defined as: Less than 5% total body weight loss after 90 consecutive days at therapeutic dose, OR Intolerable side effects documented by prescriber, OR Medical contraindication (documented allergy, drug interaction, or condition that contraindicates use) You cannot skip steps by saying you don't want to try phentermine

Glutathione intricately modulates immune responses, bolstering immune cell activity and contributing to a robust defense against pathogens and illnesses
#healthsystems, is being presented at the American Society of Clinical Oncology (ASCO) meeting
Tirzepatide generics are expected to enter the Indian market